The effects of morphine-HC1 (MOR), methionine-enkephalin (ME) and dynorphinM3 (DYN) on spinal and spino-bulbo-spinal (SBS) reflexes were studied. Although spinal intrathecal administration of MOR (15 ~tg) did not produce any apparent effect on these reflexes, systemically administered MOR (3 mg/kg i.v.) reduced the electrical toe stimulation-induced SBS reflex. Furthermore, MOR (3 mg/kg i.v.) increased the polysynaptic reflex induced by electrical stimulation of low-threshold dorsal root afferents in intact (non-spinal) rats, but not in spinal rats. Intrathecally administred DYN (0.5 and 5 gg) reduced both the electrical toe stimulation-induced spinal and SBS reflexes, while ME (15 I-tg) only reduced the SBS reflex. These results indicate the physiological multiplicity of spinal opioid receptors. MOR may affect supraspinal nuclei but not the spinal pathway which possesses MOR-sensitive opioid receptors, whereas ME and DYN affect spinal opioid peptide receptors and modulate the reflex activities in which they participate.
Introduction
It has been reported that an antinociceptive action is induced by spinal intrathecal administration of opioid peptides and opiates (Yaksh, 1981 (Yaksh, , 1983 . The increase in the firing rate of dorsal horn neurons induced by noxious stimulation is inhibited by opioid peptides (Zieglg/insberger and Bayerl, 1976; Zieglg/insberger and Tullock, 1979) , and these effects are antagonized by naloxone (North, 1979) . Polysynaptic reflexes concerned with pain, e.g,, the rat tail flick or skin twitch response, are inhibited by opioid agonists (Yaksh, 1981) .
Opioid antagonists enhance electrically evoked spinal reflex potentials in cats and rabbits (Goldfarb and Hu, 1976; Catley etal., 1983; Duggan etal., 1984 Duggan etal., , 1985 , and morphine inhibits mono-and polysynaptic reflexes in spinal 2 T. Suzuki et al. cats (Krivoy etal., 1973; Goldfarb etal., 1978) . We previously reported that opioid peptides affected the resting membrane potential of the motoneuron, the resting root potentials and spinal reflex potentials in the isolated amphibian spinal cord (Suzuki et al., 1986 (Suzuki et al., , 1987 . These observations suggest that opioid peptides or opiates affect not only nociceptive transmission but also spinal motor activity. However, it is not yet clear what type of opioid receptor modulates these spinal effects. In the present study, we attempted to clarify the spinal effects of opioid agonists on these reflexes using the technique of intrasubarachnoid space administration (Suzuki etal., 1988) .
Materials and methods
Male Wistar rats weighing 280-400 g were used. The method employed for recording the electrical toe stimulation-induced reflex was as described elsewhere (Suzuki etal., 1988) . Rats were anesthetized with ether and then injected with a-chloralose (75 mg/kg, i.p.). Under artificial respiration, the thigh part of the sciatic nerve was exposed. The reflex potentials were recorded from the central end of the dissected common peroneal nerve using a bipolar Ag--AgC1 electrode. Nerves were covered with liquid paraffin. A pair of needle electrodes were inserted subcutaneously into the ipsilateral toe for stimulation (0.2 Hz, 3 ms duration, 2-4 V intensity, rectangular pulse). Reflex potentials were amplified (Nihon Kohden, AVB-9) and averaged 8 times by an averaging computer (Nihon Kohden, ATAC-350).
The technique used for recording of mono-and polysynaptic reflexes was similar to that reported previously (Ono and Fukuda, 1982) . Rats were anesthetized with urethane (1 g/kg, i.p.) and ct-chloralose (25 mg/kg, i.p.). Laminectomy was performed in the lumbosacral region. Dorsal and ventral roots below L 4 were cut bilaterally, and the dorsal and the ventral roots of segment L 5 were placed on bipolar Ag--AgC1 electrodes for stimulation (0.2Hz, 0.05 ms duration, supramaximal intensity, rectangular pulse) and recording, respectively. The spinal cord was covered with warm liquid paraffin maintained at 36 + 0.5 ~ The reflex potentials were amplified (Nihon Kohden, AVB-10) and averaged (Nihon Kohden, DAT-1100). In some experiments, the vagus nerves were cut bilaterally at the cervical region, and the spinal cord was transected at the C 1 level.
Drugs were dissolved in physiological saline and administered into the subarachnoid space of the lumbar spinal cord (Suzuki etal., 1988) or into the femoral vein. Intrasubarachnoid space administration was performed as follows: An injection needle (27G) was inserted into the gap between the first and second lumbar vertebrae. Injection volume was 5 gl and the period of injection was 1 min. To confirm that drugs were actually administered into the subarachnoid space, the dye was injected at the end of each experiment.
Drugs used were morphine-HC1, naloxone-HC1 (Sankyo Co., Tokyo), methionineenkephalin and dynorphinl 13 (Protein Research Foundation, Osaka).
Results
Electrical toe stimulation elicited a reflex potential in the ipsilateral common peroneal nerve. The reflex potential consisted of at least two peak components, i.e., the spinal reflex component (peak 1, P 1) and the SBS reflex component (peak 2, P 2), the latencies of which were 8-10 and 25-35 ms, respectively (Suzuki et al., 1988) .
Intravenously administered morphine-HC1 (MOR, 3 mg/kg) depressed P 2. Two minutes after MOR administration, the amplitude of P 2 was reduced to Fig. 3 . Effects of administration of methionine-enkephalin (ME, 15 ~tg) into the subarachnoid space on peak amplitudes of reflexes induced by the electrical toe stimulation (A), and antagonistic effects of naloxone-HC1 (NAL, 3 mg/kg i.v.) (B). O--Q: peak 1 (P 1); O--9 peak 2 (P 2). Data are indicated as % of the control value (the value at the period of just before the drug administration). Each point represents the mean of 4 experiments, with S.E.M. indicated 36% of the control (pre-administration) level, and 20min after, to 18% of the control level. P 1 was not reduced by MOR, but rather slightly enhanced (12.5 + 6.1%, after 2rain MOR i.v., Fig. 1A ). These effects of MOR were antagonized by pre-administration of naloxone-HC1 (NAL, 0.3mg/kg, i.v., 5 min before MOR i.v., Fig. 1 B) . NAL alone did not change the amplitude of P1 orP2. Administration of MOR (15 tag) into the subarachnoid space did not induce the change in P 1 or P 2 (Fig. 2) .
Intra-subarachnoid space administration of 15 I-tg ME, the highest dose used in the present experiment, depressed P 2 but did not influence P 1 (Fig. 3 A) . The maximal depression of P 2 occured within 2 min, and the peak amplitude was depressed to 52% of the control value. Twenty minutes after the administration, P 2 had recovered to 86% of the control value. ME (1 gg) did not produce any apparent effect (data not shown). Pre-administration of NAL (3 mg/kg, i.v., 10 min before ME administration) antagonized the effect of ME (Fig. 3 B) .
Administration of dynorphinl_13 (DYN, 0.5 gg) into the subarachnoid space ] into the subarachnoid space on peak amplitudes of reflexes induced by the electrical toe stimulation, and antagonistic effects of naloxone-HC1 (3 mg/kg i.v.) on effects of DYN (0.5 lag) (C). e--O: peak 1 (P 1); 9 peak 2 (P 2). Data are indicated as % of the control value (the value at the period of just before the drug administration). Each point represents the mean of 4 experiments, with S.E.M. indicated depressed both P 1 and P 2. The maximal depressive effects on P 1 and P 2 were shown at 5 min (40% of the control value) and within 2rain (33%) after DYN administration, respectively (Fig. 4A ). These depressions of peak amplitudes had recovered to 70% of the control values after 20 min. Pre-administration of NAL (3mg/kg, i.v., 10min before DYN administration) antagonized these effects of DYN (Fig. 4 C) . At a relatively high dose of DYN (5 gg, intra-subarachnoid space administration), both P 1 and P 2 were completely depressed for 10min, and the recovery of these peak amplitudes to approximately 50% of the control values was observed at 20min after DYN administration (Fig. 4 B) . A low dose of DYN (0.05 lag) did not produce any definite effect (data not shown). MOR (3 mg/kg, i.v.) enhanced the polysynaptic reflex of the low-threshold dorsal root afferent stimulation-induced spinal reflex (PSR) in intact rats, but did not change the monosynaptic reflex (MSR, Fig. 5 A) . This effect of MOR was abolished when rats were spinalized at the C 1 level (Fig. 5 B) . 
Discussion
We have previously reported that opioid peptides modulate spinal interneuronal and motoneuronal activities in the isolated amphibian spinal cord and that morphine produces very little effect (Suzuki etal., 1986) . In the present study, no direct spinal effect of MOR was observed on either electrical toe stimulationinduced reflexes or MSR/PSR. However, systemically administered MOR depressed P 2 (SBS reflex), but not P 1, and this effect was antagonized by NAL; PSR was enhanced by MOR in intact rats. These results indicate that the spinal MOR-sensitive opioid receptors (mu-type) are not involved in the reflexes observed in this study. Thus, MOR affects the supraspinal nuclei and may elicit these effects via the descending pathways. It has been documented that the analgesic effects of MOR are caused by activation of the descending monoaminergic (especially noradrenergic) pathways (Shiomi and Takagi, 1974) . We previously reported that, in the spinal cord, intra-subarachnoid administration of noradrenaline depressed P 2, and that a relatively high dose of noradrenaline Effects of opioid agonists on spinal reflexes 7 enhanced P 1 amplitude in rats (Suzuki et al., 1988) . Furthermore, it has been documented that PSR is enhanced by al-adrenergic activation (Tanabe et al., 1987) . On the other hand, we have reported that serotonin did not depress, but rather enhanced, both P 1 and P2 (Suzuki et al., 1988) . Although some investigators have asserted that narcotic analgesia involves descending serotonergic modulation (Yaksh and Tyce, 1979) , the present results suggested that the effects of systemically administered MOR did not involve intrinsic serotonergic activation, but possibly noradrenergic activation. Since noradrenergic modulation of spinal reflexes (P 1 and PSR enhancement) may be different from modulation of the SBS reflex (inhibition) (Suzuki etal., 1988) , the effects of systemically administered MOR observed in this study might be ascribable to such noradrenergic modulation. DYN depressed P 1 and P 2, but ME depressed only P 2 at the spinal cord level. Many investigators have noted the multiplicity and different distributions of spinal opioid peptide receptors (i.e., delta-and kappa-type) (Duggan et al., 1981; Tung and Yaksh, 1982; Mack etal., 1984; Schmauss and Yaksh, 1984) . The present results indicate that DYN and ME affect different types of receptors, since under conditions in which P 2 was depressed to an equal degree by DYN and ME, the effects of these peptides on P 1 apparently differed (Figs. 3 A and 4 A). Although the difference between the physiological roles of DYN and ME in the spinal cord is not yet clear, DYN may have a more potent effect than ME in modulating reflex activities, especially spinal reflexes, in the spinal cord.
It is well known that opioid agonists produce spinal analgesic effects, and it is notable that MOR has a more potent spinal analgesic effect than ME (Yaksh, 1981 (Yaksh, , 1983 Schmauss and Yaksh, 1984) . MOR, at the dose used in this study (15 ltg), has been reported to show an apparent antinociceptive effect limited to the spinal cord (Schmauss and Yaksh, 1984) . Thus, the present results indicate that analgesic effects of opioid agonists limited to the spinal cord are not parallel the effects on reflex modulation in the spinal cord.
It has been reported that electrical toe stimulation induces the flexion reflex (Maj etal., 1976) . From the viewpoint that the SBS reflex is a mechanism producing contraction of flexion muscles in response to mechanical stimulation of the skin (Shimamura and Akert, 1965) , spinal opioid peptides may modulate the sensory-motor reflex pathways.
In summary, the opioid peptides DYN and ME produced direct spinal effects on reflex activities but MOR did not show any such effects. The discrepancy may be attributable to the difference in potency between MOR-sensitive and opioid peptides-sensitive receptors in their modulation of reflex activities. The effects of systemically administered MOR may thus account for the observed supraspinal effect.
